PCSK9 inhibitors for anti-inflammation in atherosclerosis: protocol for a systematic review and meta-analysis of randomised controlled trials.
Jichang LuoWanying LiaoXue WangRan XuWei LiWenjing LiKan LiuKaixun HuangYan MaTao WangBin YangLingyun JiaPublished in: BMJ open (2022)
CRD42022297710.